Epirus, Orygen in Brazilian biosimilars deal

Epirus Biopharmaceuticals Inc. (Boston, Mass.) partnered with the JV Orygen Biotecnologia Ltda. to develop and commercialize

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE